These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 39465746)

  • 21. Risk factors for mortality in patients with pulmonary mucormycosis.
    Son HJ; Song JS; Choi S; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    Mycoses; 2020 Jul; 63(7):729-736. PubMed ID: 32304253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invasive Fungal Infections in Immunocompromised Children: Novel Insight Following a National Study.
    Olivier-Gougenheim L; Rama N; Dupont D; Saultier P; Leverger G; AbouChahla W; Paillard C; Gandemer V; Theron A; Freycon C; Pluchart C; Blouin P; Pellier I; Thouvenin-Doulet S; Desplantes C; Ducassou S; Oudot C; Rouger-Gaudichon J; Cheikh N; Poiree M; Schneider P; Plat G; Contet A; Rialland F; Gouache E; Brethon B; Bertrand Y; Domenech C
    J Pediatr; 2021 Sep; 236():204-210. PubMed ID: 33991540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and outcome of systemic fungal infections in renal transplant recipients - A tertiary care experience.
    Shekar M; Elumalai R; Elayaperumal I; Yelahanka RP; Anandkumar DG; Bandi VK; Matcha J
    Saudi J Kidney Dis Transpl; 2019; 30(5):1137-1143. PubMed ID: 31696853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: Results from a single-centre study.
    Fracchiolla NS; Sciumè M; Orofino N; Guidotti F; Grancini A; Cavalca F; Freyrie A; Goldaniga MC; Consonni D; Mattiello V; Pettine L; Cortelezzi A
    PLoS One; 2019; 14(5):e0216715. PubMed ID: 31071175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasive fungal infection following chemotherapy for acute myeloid leukaemia-Experience from a developing country.
    Korula A; Abraham A; Abubacker FN; Viswabandya A; Lakshmi KM; Abraham OC; Rupali P; Varghese GM; Michael JS; Srivastava A; Mathews V; George B
    Mycoses; 2017 Oct; 60(10):686-691. PubMed ID: 28736936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis.
    Oh SM; Byun JM; Chang E; Kang CK; Shin DY; Koh Y; Hong J; Kim TS; Choe PG; Park WB; Kim NJ; Yoon SS; Kim I; Oh MD
    Sci Rep; 2021 Nov; 11(1):22160. PubMed ID: 34773060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
    Barreto JN; Beach CL; Wolf RC; Merten JA; Tosh PK; Wilson JW; Hogan WJ; Litzow MR
    Am J Hematol; 2013 Apr; 88(4):283-8. PubMed ID: 23460251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
    Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH
    J Microbiol Immunol Infect; 2016 Aug; 49(4):567-74. PubMed ID: 25735797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
    Busca A; Candoni A; Audisio E; Passera R; Bruno B; Monaco F; Mordini N; Vacca A; Delia M; Aversa F; Pagano L
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2214-2219. PubMed ID: 27667012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of posaconazole antifungal prophylaxis in reducing the incidence of invasive aspergillosis in patients with acute myeloid leukemia.
    Le Clech L; Uguen M; Quinio D; Nevez G; Couturier MA; Ianotto JC; Berthou C; Guillerm G; Le Bars H; Payan C; Narbonne V; Baron R; Saliou P
    Curr Res Transl Med; 2020 Jan; 68(1):23-28. PubMed ID: 31787568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for invasive fungal infection in 5-azacytidine treated patients with acute myeloid leukemia and myelodysplastic syndrome.
    Tey A; Shaw B; Cardamone L; Shepherd S; Paul E; Rogers B; Shortt J
    Eur J Haematol; 2021 Aug; 107(2):181-189. PubMed ID: 33829584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Invasive fungal infections among critically ill adult COVID-19 patients: First experiences from the national centre in Hungary.
    Szabo BG; Lakatos B; Bobek I; Szabo E; Szlavik J; Vályi-Nagy I
    J Mycol Med; 2021 Dec; 31(4):101198. PubMed ID: 34428666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A retrospective Italian analysis on the characteristics of invasive fungal infections in the intensive care unit setting: CHARTER-IFI study.
    Viale PL; Mirandola S; Natalini C; Esposti LD; Dovizio M; Veronesi C; Forcina G; Navalesi P; Boscolo A
    Mycoses; 2024 Aug; 67(8):e13779. PubMed ID: 39101705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of invasive fungal infections in immunocompromised children; an Australian national 10-year review.
    Bartlett AW; Cann MP; Yeoh DK; Bernard A; Ryan AL; Blyth CC; Kotecha RS; McMullan BJ; Moore AS; Haeusler GM; Clark JE
    Pediatr Blood Cancer; 2019 Apr; 66(4):e27564. PubMed ID: 30511385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breakthrough invasive fungal infection in patients with myeloid malignancy receiving posaconazole tablet prophylaxis: Clinical features, risk factors, and posaconazole profiles.
    Hong JY; Kang CI; Yang J; Ko JH; Huh K; Cho SY; Chung DR; Jung CW; Peck KR
    Med Mycol; 2023 Apr; 61(5):. PubMed ID: 37120735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections.
    Verma N; Singh S; Taneja S; Duseja A; Singh V; Dhiman RK; Chakrabarti A; Chawla YK
    Liver Int; 2019 Mar; 39(3):503-513. PubMed ID: 30276951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invasive fungal infections in patients with haematological malignancies at the University Hospital of Reunion Island (2018-2022): An observational study.
    Estagnasié C; Mohr C; Kamus L; Zunic P; Chirpaz E; Moiton MP; Lagrange-Xelot M
    Med Mycol; 2024 Oct; 62(10):. PubMed ID: 39406396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and Predictors of Invasive Fungal Infections in Children with Persistent Febrile Neutropenia Treated for Acute Leukemia - A Prospective Study.
    Kumar J; Singh A; Seth R; Xess I; Jana M; Kabra SK
    Indian J Pediatr; 2018 Dec; 85(12):1090-1095. PubMed ID: 29956075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fungal infections of the central nervous system and paranasal sinuses in onco-haematologic patients. Epidemiological study reporting the diagnostic-therapeutic approach and outcome in 89 cases.
    Candoni A; Klimko N; Busca A; Di Blasi R; Shadrivova O; Cesaro S; Zannier ME; Verga L; Forghieri F; Calore E; Nadali G; Simonetti E; Muggeo P; Quinto AM; Castagnola C; Cellini M; Del Principe MI; Fracchiolla N; Melillo L; Piedimonte M; Zama D; Farina F; Giusti D; Mosna F; Capelli D; Delia M; Picardi M; Decembrino N; Perruccio K; Vallero S; Aversa F; Fanin R; Pagano L;
    Mycoses; 2019 Mar; 62(3):252-260. PubMed ID: 30565742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients.
    Miceli MH; Churay T; Braun T; Kauffman CA; Couriel DR
    Mycopathologia; 2017 Jun; 182(5-6):495-504. PubMed ID: 28124219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.